Abstract 7112: Preclinical profile of novel and potent small molecule inhibitors of PARG
Patra, Sukanya, Pothuganti, Manoj, Kummari, Githavani, Sankeshi, Venu, Kapaka, Jyothipriya, Karche, Navnath, Mekala, Ramamohan, Viswanadha, Srikant
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract A099: Best in class, potent, SOS1 inhibitors demonstrate single agent activity in preclinical models of KRAS driven tumors
Lakhavath, Balakrishna, Pothuganti, Manoj, Kummari, Githavani, Pathange, Hemasankar, Sekar, Rajan, Viswanadha, Srikant
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract A024: Preclinical profile of novel and potent small molecule inhibitors of KIF18A inhibitors in chromosomally unstable solid tumor lines
Patra, Sukanya, Pothuganti, Manoj, Karche, Navnath, Gudade, Ganesh, Sankeshi, Venu, Kummari, Githavani, Vishwanadha, Srikant
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Protein kinase A mediates novel serine-584 phosphorylation of HDAC4
Doddi, Shanmukha K, Kummari, Githavani, M.V, Jagannadham, Kalle, Arunasree M
Published in Biochemistry and cell biology (01.10.2019)
Published in Biochemistry and cell biology (01.10.2019)
Get full text
Journal Article
Abstract 6368: Discovery of potent, orally bioavailable, SOS1 inhibitors for KRAS-driven tumors
Sasmal, Sanjita, Patra, Sukanya, Boorgu, Venkatesham, Yanamadra, Mahesh, Ettam, Ashok, Dunaboyina, Nagaraju, Kummari, Githavani, Yengala, Ram Mohan, Lakhavath, Balakrishna, Das, Jayita, Sunkanapally, Satheesh, Reddy, Pravalika, Mathew, Megha Mariam
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article